The registry report of heart transplantation in Japan (1999-2013).
نویسندگان
چکیده
below, most of the patients undergoing heart transplantation are on some form of LVAD as BTT. At first, extracorporeal devices were the norm. Implantable devices were initially only used as part of clinical trials, but BTT therapy using an implantable LVAD, allowing treatment at home, is increasingly coming into use since medical insurance coverage became available for nonpulsatile implantable LVADs in April 2011.
منابع مشابه
The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report--2013; focus theme: age.
This section of the 30th official Registry report of 2013 summarizes data from 43,428 adult lung and 3,703 adult heart-lung transplant recipients and their donors for transplants that occurred through June 30, 2012. This report describes donor and recipient characteristics, transplant type, and recipient outcomes data. The full Registry slide set available online (www.ishlt.org/registries) prov...
متن کاملThe Registry of the International Society for Heart and Lung Transplantation: Fourteenth Pediatric Lung and Heart-Lung Transplantation Report--2011.
This Fourteenth Pediatric Lung and Heart-Lung Transplantation Report covers the pediatric lung transplantation and heart-lung transplantation experience from January 1986 through June 2010. During this period, 1,664 pediatric lung transplant procedures and 653 pediatric heart-lung transplant procedures were reported to the International Society for Heart and Lung Transplantation (ISHLT) Registr...
متن کاملThe Registry Report of Heart Transplantation in Japan (1999-2014).
formed under the newly introduced Organ Transplant Law in February 1999. The number of heart transplants per year rose from 3 initially to 5, then to nearly 10. After the legislative amendments it rose to 30 and then 37 per year (Figure 1). Most of the early VADs used for BTT were extracorporeal devices, with implantable devices used mainly for clinical research or experimental trials of at-hom...
متن کاملFeasibility of high-dose iodine-131-metaiodobenzylguanidine therapy for high-risk neuroblastoma preceding myeloablative chemotherapy and hematopoietic stem cell transplantation: a study protocol
Objective(s): High-risk neuroblastoma is a childhood cancer with poorprognosis despite modern multimodality therapy. Internal radiotherapy using131I-metaiodobenzylguanidine (MIBG) is effective for treating the disease even if it isresistant to chemotherapy. The aim of this study is to evaluate the safety and efficacyof 131I-MIBG radiotherapy combined with myeloablative high-dose chemotherapyand...
متن کاملAnnual Report of the German Renal Registry 1998. QuaSi-Niere Task Group for Quality Assurance in Renal Replacement Therapy.
During the past 3 years, the basis of a German Renal Registry has been established. An agreement between end-stage renal disease (ESRD) therapy providers, insurance companies and the government has been reached to fund and support the registry office and its electronic data base. An overall acceptable compliance has been achieved to provide data voluntarily, although in the future the data subm...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Circulation journal : official journal of the Japanese Circulation Society
دوره 78 11 شماره
صفحات -
تاریخ انتشار 2014